Cleaning Validation in Pharma: Basics and Acceptance Limits

Cleaning validation is documented evidence that a cleaning procedure consistently removes product residues, cleaning agents and microbial contamination from equipment to predefined, scientifically justified limits. Today those limits are expected to rest on a toxicological evaluation, usually a health-based exposure limit such as the permitted daily exposure (PDE), rather than on the older 10 ppm and 1/1000 dose criteria alone.

In a shared facility, cleaning is the main barrier against cross-contamination, a failure that finished-product testing rarely detects. Inspectors in India and the GCC review it closely, from limit calculations to the way operators hold a swab.

Regulatory expectations

Key texts include the following (check current versions):

• EU GMP Annex 15, section 10: limits based on toxicological evaluation, justified worst cases and hold times.
• EMA guideline on setting health-based exposure limits for shared facilities, with its questions and answers, on deriving PDEs.
• EU GMP Chapters 3 and 5: assessing and controlling cross-contamination risk.
• 21 CFR 211.67 for US-regulated equipment, plus FDA's long-standing guide to inspections of cleaning validation.
• WHO GMP and India's revised Schedule M, which also expect validated cleaning, as do GCC regulators.

Annex 15 makes two points that catch many sites out. A visual check alone is generally not acceptable as the only criterion, and repeated cleaning and testing until results pass (test until clean) is not an acceptable alternative to validation.

Worst-case grouping of products and equipment

Validating every product on every item is rarely practical, so products and equipment are grouped and a justified worst case is validated for each group. Factors for the worst-case product include:

• Lowest health-based limit, meaning the most potent or toxic residue.
• Poorest solubility in the cleaning medium.
• Hardest to clean, ideally shown by laboratory cleanability studies rather than opinion.
• Highest concentration of active substance in the formulation.

Equipment of the same design and material can be grouped with a documented rationale. Within each item, hardest-to-clean locations such as punch faces, gaskets and spray nozzles become sampling points.

Sampling: swab vs rinse

Swab sampling wipes a defined area, often a hardest-to-clean location, and can reach dried-on residue. Rinse sampling collects a final rinse that has contacted all product-contact surfaces, which suits pipework and vessels a swab cannot reach. Many programmes combine both.

Neither method recovers all of the residue. A recovery study spikes coupons of each material of construction with known amounts of residue near the limit, which samplers recover using the routine technique. The recovery factor corrects results, and each sampler should be qualified, because technique strongly affects recovery.

Analytical methods

Methods may be specific, such as HPLC or UV for a named active substance, or non-specific, such as total organic carbon (TOC) or conductivity, which respond to any residue and are useful for detergents. A non-specific result can be acceptable if it is all attributed to the worst-case residue.

Validate the method for this purpose following ICH Q2(R2), with a limit of quantitation well below the acceptance limit (see LOD vs LOQ). Include microbial limits and, for parenteral equipment, endotoxin where relevant.

Setting acceptance limits

Historically, many sites used the lowest of three criteria: 10 ppm, 1/1000 of the minimum therapeutic dose, and no visible residue. These are simple but not linked directly to toxicity.

Health-based limits start with a PDE or acceptable daily exposure (ADE), derived by a qualified toxicologist from all available data. The PDE is converted to a maximum allowable carryover (MACO), commonly calculated as the PDE multiplied by the minimum batch size of the next product, divided by its maximum daily dose. The MACO is divided by the total shared product-contact surface area to give a limit per unit area, and then per swab.

Where a legacy limit is stricter and consistently met, many sites keep it as an internal limit. Where the health-based limit is stricter, it takes precedence.

Visual checks, hold times and verification

Visual inspection should be defined: who inspects, under what lighting and which surfaces. It is often the first sign that a procedure is drifting.

Two hold times must be supported by data. The dirty hold time is the maximum time between the end of production and the start of cleaning, after which residues may dry and become harder to remove. The clean hold time is the maximum time cleaned equipment may be stored before use without recontamination. Campaign length also needs justification.

Cleaning verification tests equipment after a specific clean, for example after a one-off product or an investigation. Cleaning validation shows the procedure works consistently, so routine cleans do not each need full testing. The number of validation runs should be justified by risk; three consecutive runs remain a common convention.

Worked example: a multi-product tablet facility in Gujarat

A multi-product tablet plant near Vadodara makes 14 products on two shared trains (granulation, drying, blending and compression) plus a shared coating pan. A new product with a much lower PDE than any current product prompts QA to move the whole programme from legacy 10 ppm limits to health-based limits.

1. Toxicology: a qualified toxicologist prepares PDE assessments for all 15 products.
2. Recalculate limits: MACO values are calculated for every changeover using each train's shared surface area. For two older products, the new limits are tighter than the legacy ones.
3. Re-select the worst case: laboratory cleanability tests show the new product is poorly water-soluble and the hardest to clean, so it becomes the worst case for both trains.
4. Update sampling: the swab map adds punch faces and coating pan spray nozzles. Recovery studies cover stainless steel and the nozzle polymer.
5. Execute and investigate: the first validation run fails at a coating pan baffle. Investigation finds inconsistent manual brushing, so the SOP is rewritten with defined tools and sequence, operators are retrained and the runs are repeated successfully.
6. Maintain: hold times are confirmed at maximum planned durations, and new products enter through change control.

Common mistakes

• Relying on 10 ppm or 1/1000 dose limits without a health-based assessment.
• Using visual cleanliness as the only acceptance criterion.
• Skipping recovery studies or using a different swab technique from the one validated.
• Choosing the worst-case product by opinion instead of data.
• Treating cleaning validation as a one-off rather than reviewing it when products or equipment change.

Key takeaway: Cleaning validation is only as strong as its limits and its sampling. Base limits on health-based exposure values, prove recovery from real surfaces, and keep the programme alive through change control.

Frequently Asked Questions

What is the 10 ppm criterion in cleaning validation?

It is a historical limit stating that no more than 10 parts per million of the previous product should appear in the next product. It is simple but not linked to toxicity, so EMA and PIC/S now expect health-based limits, with legacy criteria kept only where they are stricter.

What is PDE in cleaning validation?

PDE stands for permitted daily exposure, a substance-specific dose unlikely to cause an adverse effect if a person is exposed to it every day for a lifetime. A qualified toxicologist derives it, following the EMA guideline on health-based exposure limits. The PDE is used to calculate the maximum allowable carryover into the next product.

Is swab or rinse sampling better?

Neither is better in every case. Swab sampling directly tests hardest-to-clean locations and dried residues, while rinse sampling covers large or inaccessible surfaces such as pipework. Many programmes use both. Whichever you choose, support it with recovery studies on each material of construction and trained, qualified samplers.

What is dirty hold time?

Dirty hold time is the maximum validated time that equipment can remain uncleaned after production before cleaning starts. Longer holds can let residues dry and microorganisms grow, making cleaning harder. Sites confirm it by cleaning equipment after the maximum planned hold and showing that results still meet acceptance limits.

Next steps

Our Pharmaceutical Microbiology & Contamination Control course covers contamination control strategy, including the microbial side of cleaning, and Internal Auditing & Audit Readiness Essentials helps you test your programme before an inspector does. For related reading, see method validation vs verification, IQ, OQ, PQ explained and process validation stages explained. You can also speak to a counsellor.